CD163 and hematoma: Through HCAR2-dependent regulation of the CD36/CD163/HO-1 axis, niacin enhances M2 microglial phagocytosis, accelerates hematoma clearance, reduces hydrocephalus, and improves neurological outcomes while mitigating neuroinflammation and oxidative stress.